Autoimmune nodopathies, an emerging diagnostic category
Por:
Martin-Aguilar, L, Lleixa, C, Pascual-Goni, E
Publicada:
1 oct 2022
Resumen:
Purpose of review
In the last decade, antibodies targeting cell adhesion molecules of the node of Ranvier were described in patients with autoimmune neuropathies. These nodal/paranodal antibodies associate with specific clinicopathological features that are different from classical chronic inflammatory demyelinating polyneuropathy (CIDP). In this review, we will summarize recent findings establishing autoimmune nodopathies (AN) as a new category of autoimmune neuropathies.
Recent findings
AN include anti-contactin 1, anti-contactin-associated protein 1, anti-neurofascin 155 and anti-panneurofascin antibody-mediated neuropathies. Their clinical spectrum includes acute, subacute or chronic onset sensory-motor neuropathies mimicking Guillain-Barre syndrome (GBS) and CIDP, although they differ in their response to standard therapy with intravenous immunoglobulin (IVIG). Neurophysiologically they overlap with acquired demyelinating neuropathies, but ultrastructural studies and animal models demonstrated antibody-mediated pathology restricted to the node of Ranvier. Anti-contactin1 and anti-panneurofascin also associate with nephrotic syndrome. Nodal/paranodal antibodies are predominantly of the immunoglobulin (IgG)4 subclass during the chronic phase of the disease, but complement-fixing IgG3 antibodies are detected during the early phase and associate with aggressive onset and IVIG response. Nodal/paranodal antibodies testing is key in the diagnosis of AN.
Summary
AN have emerged as a new diagnostic category pathologically different from acquired demyelinating neuropathies. Clinically they overlap with GBS and CIDP although they associate with specific clinical features that should lead to clinical suspicion. Nodal/paranodal antibodies are key effector mechanisms of disease and good diagnostic and disease-monitoring biomarkers in AN.
Filiaciones:
Martin-Aguilar, L:
Univ Autonoma Barcelona, Dept Neurol, Neuromuscular Dis Unit, Hosp Santa Creu & St Pau, Barcelona, Spain
Lleixa, C:
Univ Autonoma Barcelona, Dept Neurol, Neuromuscular Dis Unit, Hosp Santa Creu & St Pau, Barcelona, Spain
Pascual-Goni, E:
Univ Autonoma Barcelona, Dept Neurol, Neuromuscular Dis Unit, Hosp Santa Creu & St Pau, Barcelona, Spain
|